Genetic analysis of the GRM1 gene in human melanoma susceptibility

European Journal of Human Genetics

Volumn 15, Issue 11, 2007, Pages 1176-1182

  Ortiz, Pablo ^a   Vanaclocha, Francisco ^a   López Bran, Eduardo ^b   Esquivias, José Ignacio ^b   López Estebaranz, José Luis ^c   Martín González, Manuel ^d   Arrue, Itziar ^a   García Romero, Diana ^a   Ochoa, Carolina ^e   González Perez, Antonio ^e   Ruiz, Agustin ^e   Real, Luis Miguel ^e  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

^e UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Genetics; Glutamate; GRM1; Melanoma; Polymorphisms

Indexed keywords

G PROTEIN COUPLED RECEPTOR; PROTEIN GRM1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INTRON; LIMB; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SUN EXPOSURE; TRUNK;

CASE-CONTROL STUDIES; EXTREMITIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MELANOMA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, METABOTROPIC GLUTAMATE; SUNLIGHT;

EID: 35548984436     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201887     Document Type: Article

References (29)

1. Parkin DM, Pisani P, Ferlay J: Estimates of the world-wide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594-606.
2. Weinstock MA: Epidemiology, etiology, and control of melanoma. Med Health R I 2001; 84: 234-236.
3. Marks R: Epidemiology of melanoma. Clin Exp Dermatol 2000; 25 459-463.
4. Whiteman DC, Whiteman CA, Green AC: Childhood sun exposure as a risk factor for melanoma: A systematic review of epidemiologic studies. Cancer Causes Control 2001; 12: 69-82.
5. Elwood JM: Melanoma and sun exposure. Semin Oncol 1996; 23: 650-666.
6. Elwood JM, Gallagher RP: Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure. Int J Cancer 1998; 78: 276-280.
7. Beral V, Robinson N: The relationship of malignant melanoma, basal and squamous skin cancers to indoor and outdoor work. Br J Cancer 1981; 44: 886-891.
8. Vagero D, Ringback G, Kiviranta H: Melanoma and other tumours of the skin among office, other indoor and outdoor workers in Sweden 1961-1979. Br J Cancer 1986; 53: 507-512.
9. Titus-Ernstoff L, Perry AE, Spencer SK, Gibson Jj, Cole BF, Ernstoff MS: Pigmentary characteristics and moles in relation to melanoma risk. Int J Cancer 2005; 116: 144-149.
10. Fargnoli MC, Piccolo D, Altobelli E, Formicone F, Chimenti S, Peris K: Constitutional and environmental risk factors for cutaneous melanoma in an Italian population. A case-control study. Melanoma Res 2004; 14: 151-157.
11. Kennedy C, ter Huurne J, Berkhout M et al: Melanocortin 1 receptor (MC1R) gene variants are. associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 2001; 117: 294-300.
12. Millikan RC, Hummer A, Begg C et al: Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: The Genes Environment and Melanoma Study. Carcinogenesis 2006; 27: 610-618.
13. Kumar R, Smeds J, Berggren P et al: A single nucleotide polymorphism in the 3′untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare. Int J Cancer 2001; 95: 388-393.
14. Konishi R, Sakatani S, Kiyokane K, Suzuki K: Polymorphisms of p21 cyclin-dependent kinase inhibitor and malignant skin tumours. J Dermatol Sci 2000; 24: 177-183.
15. Meyer P. Sergi C, Garbe C: Polymorphisms of the BRAF gene predispose males to malignant melanoma. J Carcinog 2003; 2: 7-11.
16. Amend KL, Eder JT, Tomsho LP et al: EGF gene polymorphism and the risk of incident primary melanoma. Cancer Res 2004; 64: 2668-2672.
17. Zhu H, Reuhl Y, Zhang X et al: Development of heritable melanoma in transgenic mice. J Invest Dermatol 1998; 110: 247-252.
18. Pollock PM, Cohen-Solal K, Sood R et al: Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat Genet 2003; 34: 108-112.
19. Dhanasekaran N, Heasley LE, Johnson GL: G protein-coupled receptor systems involved in cell growth and oncogentsis. Endocr Rev 1995; 16: 259-270.
20. Takano T, Lin JH, Arcuino G, Gao Q Yang J, Nedergaard M: Glutamate release promotes growth of malignant gliomas. Nat Med 2001; 7 1010-1015.
21. Rzeski W, Turski L, Ikonomidou C: Glutamate antagonists limit tumour growth. Proc Natl Acad Sci USA 2001; 98: 6372-6377.
22. Berwick M, Armstrong BK, Ben-Porat L et al: Sun exposure and mortality from melanoma. J Natl Cancer Inst 2005; 97: 195-199.
23. Sasieni PD: From geDotypes to genes: doubling the sample size. Biometrics 1997; 53: 1253-1261.
24. Bastian BC, Olshen AB, LeBoit PE, Pinkel D: Classifying melanocytic tumours based on DNA copy numbei changes. Am J Pathol 2003; 163 1765-1770.
25. Curtin JA, Fridlyand J, Kageshita T et al: Distinct sets of genetic alterations in melanoma. N Engl J Med 2005; 353: 2135-2147.
26. Maldonado JL, Fridlyand J, Patel H et al: Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 2003; 95: 1878-1890.
27. Cohen C, Zavala-Pompa A, Sequelra JH et al: Mitogen-activated protein kinase activation is an early event in melanoma progression. Clin Cancer Res 2002; 8: 3728-3733.
28. Marin YE, Chen S: Involvement of metabotropic glutamate receptor 1, a G protein coupled receptor, in melanoma development. J Mol Med 2004; 82: 735-749.
29. Marin YE, Namkoong J, Cohen-Solal K et al: Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1/2 via PKCepsilon. Cell Signal 2006; 18: 1279-1286.